LABORATORIO FARMAC.ERFO Working Capital to Net Assets Ratio
LABORATORIO FARMAC.ERFO working capital to net assets ratio. LABORATORIO FARMAC.ERFO (RK7) has a Working Capital to Net Assets ratio of 20.1% as of June 2024. Working capital of €1.52 Million (current assets of €3.99 Million minus current liabilities of €2.48 Million) is measured against net assets of €7.54 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check RK7 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of LABORATORIO FARMAC.ERFO (2021–2021)
Working capital to net assets ratio of LABORATORIO FARMAC.ERFO from 2021 to 2021. This chart shows how LABORATORIO FARMAC.ERFO's Working Capital to Net Assets ratio has evolved across 1 annual periods from 2021 to 2021. As of June 2024, the ratio stands at 20.1%, reflecting working capital of €1.52 Million against net assets of €7.54 Million EUR. See defensive interval ratio of LABORATORIO FARMAC.ERFO to measure how many days the company can operate on defensive assets alone.
LABORATORIO FARMAC.ERFO Working Capital to Net Assets Ratio by Year (2021–2021)
LABORATORIO FARMAC.ERFO working capital to net assets ratio by year from 2021 to 2021. The table below presents the year-by-year Working Capital to Net Assets ratio for LABORATORIO FARMAC.ERFO from 2021 to 2021, covering 1 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see LABORATORIO FARMAC.ERFO total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 5.5% | €258.00K | €4.73 Million | €1.57 Million | €1.31 Million | — |